| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ACORN BIOVENTURES, L.P. | 6.2% | -11.4% | $13.3M | -$1.43M | 2.8M | -9.69% | Anders Hove | 19 Aug 2025 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Change | Price | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 16.4K | $78.3K | -$125M | $6.66 | 2 |
| 2025 Q2 | 27.9M | $126M | -$3.99M | $4.51 | 96 |
| 2025 Q1 | 28.8M | $128M | -$6.93M | $4.43 | 102 |
| 2024 Q4 | 28.8M | $225M | -$943K | $7.83 | 111 |
| 2024 Q3 | 25.7M | $339M | +$17.3M | $13.15 | 105 |
| 2024 Q2 | 24.3M | $294M | +$14.8M | $12.08 | 95 |
| 2024 Q1 | 23M | $374M | +$49.1M | $16.26 | 94 |
| 2023 Q4 | 20.2M | $138M | +$5.16M | $6.82 | 93 |
| 2023 Q3 | 19.7M | $107M | +$812K | $5.45 | 98 |
| 2023 Q2 | 19.5M | $132M | +$4.78M | $6.79 | 94 |
| 2023 Q1 | 19M | $95.4M | -$1.13M | $5.01 | 84 |
| 2022 Q4 | 19.3M | $94.4M | -$55.2M | $4.88 | 90 |
| 2022 Q3 | 23.6M | $340M | -$17.9M | $14.42 | 95 |
| 2022 Q2 | 24.8M | $375M | -$7.58M | $15.13 | 90 |
| 2022 Q1 | 25.3M | $301M | -$14.9M | $11.88 | 87 |
| 2021 Q4 | 25.7M | $417M | -$24.2M | $16.21 | 94 |
| 2021 Q3 | 26.2M | $749M | -$2.98M | $28.54 | 96 |
| 2021 Q2 | 26.1M | $887M | -$1.16M | $33.80 | 99 |
| 2021 Q1 | 26.3M | $796M | +$116M | $30.24 | 116 |
| 2020 Q4 | 22.8M | $1.13B | +$38.4M | $49.51 | 115 |
| 2020 Q3 | 21.4M | $823M | +$3.02M | $38.39 | 105 |
| 2020 Q2 | 21.3M | $920M | +$53.4M | $43.20 | 108 |
| 2020 Q1 | 20.1M | $522M | +$16M | $26.10 | 80 |
| 2019 Q4 | 19.4M | $606M | +$185M | $31.25 | 81 |
| 2019 Q3 | 13.1M | $342M | +$56.5M | $26.06 | 65 |
| 2019 Q2 | 11M | $251M | +$54.3M | $22.87 | 59 |
| 2019 Q1 | 8.48M | $222M | -$3.12M | $26.21 | 44 |
| 2018 Q4 | 8.69M | $176M | +$16.9M | $20.34 | 42 |
| 2018 Q3 | 7.73M | $205M | +$205M | $26.56 | 38 |